Companies › Indivior

Indivior

Company Other

Indivior is listed as a company in Other. It has filed 1 comment letter on 1 proposed federal rule in 2023, most often with the Drug Enforcement Administration.

Type
Company
Industry
Other
Comment letters
1
Rules commented on
1
First letter
2023-03-31
Latest letter
2023-03-31
Agencies most often
Drug Enforcement Administration (1)

Activity by year

20231

Letters

2023

Expansion of Induction of Buprenorphine via Telemedicine Encounter

DEA-2023-0028Justice Department, Drug Enforcement Administration · filed 2023-03-31